You're right. Unless the mm's get a wild hare & make XKEM the flavor of the month, we'll see a bit of a move north with loans but nothing crazy until factory completion. After that, need to really ramp up distribution. Long term winner, short term... let's just say, I'm not retiring on XKEM this week.
They have allready done the clinical studies, and if I remember correctly 94% no longer had the sickle cell crissis and the other 6% that had it did not cure had the crissis less frequently and with shorter duration and less pain. (my %numbers are off a little bit)
It helps EVERYONE with this dreadful disease. Glory be to God.
News 
Market Data 
Discover 
AI
